Journal Jam 1: Age Adjusted D-dimer with Jeff Kline and Jonathan Kirschner
Emergency Medicine Cases
Dr. Anton Helman
4.7 • 602 Ratings
🗓️ 15 September 2014
⏱️ 34 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | I'm Anton Helman, and I'm Teresa Chan. |
| 0:08.0 | And this is the Journal Jam podcast, where we blend interviews with leading researchers of important emergency medicine journal articles. |
| 0:18.1 | With the Annals of Emergency Medicine and academic life in emergency medicine, joint global |
| 0:23.5 | emergency medicine journal talk. |
| 0:25.2 | And the best of crowdsourced social media-based opinions of emergency medicine providers |
| 0:29.8 | from around the world. |
| 0:32.9 | In this first ever episode of the Journal Jam podcast, Teresa and I are super stoked to talk about the potential for age-adjusted D-Dimer to rule out pulmonary embolism in low-risk patients over the age of 50. |
| 0:46.0 | Now, we all know from experience that PE can be excruciatingly difficult to diagnose clinically because the symptoms and signs are often non-specific and overlap with a whole |
| 0:55.5 | slew of other diagnoses like pneumonia, for example. For years, we've been using the well |
| 1:00.8 | score to help us categorize patients as low, medium, or high risk, and then use it to help us |
| 1:06.5 | decide which patients we might be able to rule out PE with a negative D-Dimer. |
| 1:12.5 | So the problem till now has been that the older the patient, the more likely the D-Dimer is to be |
| 1:18.1 | positive whether they have a P-E or not. So many of us have thrown the D-Dimer out the window |
| 1:23.4 | in older patients and go straight to CTPA, which if you're a risk-averse doc might lead to |
| 1:30.0 | over-utilization of resources, huge costs, increased length of stay, increased radiation effects, |
| 1:36.6 | etc. And if you're not so risk-averse, then you might miss P.E.s in older patients, |
| 1:41.4 | and we don't want that to happen either. So the format of this podcast |
| 1:45.1 | is that Teresa and I will give you a bit of background on the adjust PE trial. We'll describe the |
| 1:50.6 | paper itself, and then we'll jump into the interview that Sam Sheikh, Anand Swami Nathan, |
| 1:56.4 | and Salim Raseh from Academic Life and Emergency Medicine, due with Jeff Klein, who's the vice chair |
| 2:02.4 | for research at the Indiana University of School of Medicine and probably the world's most |
| 2:07.4 | important researcher in thrombolic disease from an emergency medicine perspective, as well as |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Dr. Anton Helman, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Dr. Anton Helman and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.
